The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase IB/II study of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer (KCSG BR18-16).
 
Se Hyun Kim
Consulting or Advisory Role - Ono Pharmaceutical
 
Koung Jin Suh
No Relationships to Disclose
 
Seock-Ah Im
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; GlaxoSmithKline; Hanmi; Lilly; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Daewoong Pharmaceutical (Inst); Eisai (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Other Relationship - Roche
 
Kyung-Hun Lee
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer
 
Min Hwan Kim
No Relationships to Disclose
 
Joohyuk Sohn
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Other Relationship - Roche
 
Yeon Hee Park
Honoraria - Merck; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Eisai; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Gencurix (Inst); Novartis; Pfizer; Roche (Inst)
 
Ji-Yeon Kim
No Relationships to Disclose
 
Jae Ho Jeong
No Relationships to Disclose
 
Kyoung Eun Lee
No Relationships to Disclose
 
In Sil Choi
No Relationships to Disclose
 
Kyong Hwa Park
Honoraria - Celltrion
 
Hee Jun Kim
No Relationships to Disclose
 
Eun Kyung Cho
No Relationships to Disclose
 
So Yeon Park
No Relationships to Disclose
 
Milim Kim
No Relationships to Disclose
 
Jee Hyun Kim
Honoraria - AstraZeneca; Eisai; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Bixink; Daiichi Sankyo/Astra Zeneca; Eisai; Novartis; Pfizer; Roche; Yuhan
Research Funding - Ono Pharmaceutical (Inst); Roche (Inst)